Archives
-
Fludarabine DNA Synthesis Inhibitor Workflows
2026-09-10
Build reproducible Fludarabine workflows for cell-cycle arrest, apoptosis, leukemia research, and multiple myeloma research. The same compound can also support carefully controlled studies of lymphodepletion and antigen presentation, provided regimen-level immunotherapy findings are not overinterpreted as effects of Fludarabine alone.
-
2-Deoxy-D-glucose: Practical Glycolysis Workflows
2026-09-09
2-Deoxy-D-glucose (2-DG) provides a practical way to perturb glucose dependence, ATP production, and metabolic stress across cancer, osteoblast, and antiviral models. This guide connects concentration planning and troubleshooting with a recent Wnt–glycolysis study, helping researchers distinguish pathway-specific biology from nonspecific cytotoxicity.
-
Hexamethonium Bromide in Autonomic Research
2026-09-09
Hexamethonium Bromide provides a mechanistic way to interrogate autonomic ganglionic transmission rather than merely describe blood-pressure phenotypes. This article explains how to interpret ganglionic blockade in sex-specific hypertension research and how B1592 can support rigorous neuronal signaling studies.
-
Computational Modeling of Rodent Depression Tests
2026-09-08
A 2025 Cell Reports Methods study combines automated tracking with computational modeling to examine the cognitive processes expressed during forced swim and tail suspension tests. Its findings show that the assays share some reinforcement-learning features but are not interchangeable, while learning-related influences dominate early behavior and consequence sensitivity becomes more important later.
-
TTP, m6A, and Fibrosis in Schistosomiasis
2026-09-08
The reference study identifies tristetraprolin as an antifibrotic regulator that enhances WTAP-dependent m6A modification of TGF-β1 mRNA, reducing transcript stability and hepatic stellate cell activation. Its combination of disease modeling, molecular perturbation, MeRIP-seq, transcriptomics, and proteomics provides a mechanistic framework for studying epitranscriptomic control of schistosomiasis-associated liver fibrosis.
-
ECL Chemiluminescent Substrate Detection Kit Workflow
2026-09-07
Build a sensitive, flexible western blot workflow for low-abundance targets using HRP-based detection on nitrocellulose or PVDF. This practical guide connects substrate handling, exposure strategy, assay optimization, and pathway-focused validation to the SVP3 hypolipidemia study.
-
GSK-923295: A Practical CENP-E Inhibitor Workflow
2026-09-07
GSK-923295 provides a chemically defined way to interrogate CENP-E-dependent chromosome congression, mitotic arrest, and tumor-cell sensitivity. This workflow connects acute motor inhibition with the centromere architecture insights of recent CTCF research, helping investigators distinguish kinetochore motor defects from broader centromere-maintenance phenotypes.
-
Rocket-Like Nanomedicine Restores PDAC Stromal Homeostasis
2026-09-05
The reference study develops an acid-responsive, sequential-release nanomedicine that remodels pancreatic tumor stroma before delivering gemcitabine. In a pancreatic ductal adenocarcinoma mouse model, the Si-G@Ca-H/uPA platform produced marked tumor regression without reported treatment-related side effects, supporting stromal reprogramming as a delivery strategy rather than simple stromal depletion.
-
RBMS1 Loss Enables PD-L1 Blockade in TNBC
2026-09-04
The reference study identifies the RNA-binding protein RBMS1 as a regulator of immune-cold triple-negative breast cancer through control of PD-L1 stability. Its mechanistic model links RBMS1-dependent B4GALT1 mRNA stability to PD-L1 glycosylation, suggesting a strategy for improving T-cell-based and immune checkpoint therapies.
-
Puerarin, Gut Microbiota, and Adipose Thermogenesis
2026-09-04
A 2026 Phytotherapy Research study links puerarin’s metabolic benefits in diabetic mice to coordinated changes in gut microbiota, fecal butyrate, GLP-1 secretion, and adipose-tissue thermogenesis. By combining 16S rRNA sequencing, metabolomics, gene-expression analysis, and western blotting, the study proposes a microbiota–adipose axis involving PI3K/AKT and PPARγ signaling, while leaving important questions about causality and clinical translation open.
-
Acifran Workflows for Lipid Signaling Research
2026-09-03
Acifran enables matched-receptor experiments that connect HM74A/GPR109A and GPR109B activation with Gi-linked cAMP and lipid phenotypes. This workflow combines structure-guided assay design, practical solution handling, and troubleshooting for more interpretable lipid metabolism research.
-
Sulfaphenazole-Derived Sulfonamides for Safer Anti-TB
2026-09-03
Chen and colleagues optimized sulfaphenazole-derived sulfonamides to retain antimycobacterial activity while reducing CYP 2C9 inhibition, a potential source of drug–drug interactions. Compound 10d was the leading example, combining a reported MIC of 5.69 μg/mL with CYP 2C9 inhibition above 10 μM and low cytotoxicity.
-
Romidepsin (FK228) Cancer Research Workflows
2026-09-02
Build reproducible HDAC1/2 inhibition experiments with Romidepsin, from solvent handling and dose–response design to chromatin, apoptosis, and proteomic readouts. A multidimensional proteomics study of platycodin D provides a useful target-validation framework, while its distinct biology also clarifies what Romidepsin experiments can—and cannot—claim.
-
Alpha-Ketoglutarate: Designing Causal Metabolism Assays
2026-09-02
Explore how alpha-ketoglutarate and α-KGA can be used to design more rigorous metabolism–immunity assays. This article translates a recent cholangiocarcinoma study into practical decisions for metabolic reprogramming, enzyme activity, and tumor–macrophage research.
-
CFTRinh-172: CFTR Inhibitor Workflow Guide
2026-09-01
Use CFTRinh-172 to separate CFTR channel activity from trafficking effects in airway and intestinal epithelial assays. This practical guide covers dosing, functional validation, surface-abundance experiments, troubleshooting, and translational applications in cystic fibrosis research and secretory diarrhea models.